Healio1d
Adults who receive Epstein–Barr donor kidneys face risk of post-transplant complications
Patients who receive kidney transplants from Epstein–Barr virus D-positive/R-negative donors face a higher risk of ...
AI advancement in T cell epitope prediction could propel vaccine development
A collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging ...
News Medical on MSN12h
New AI tool promises faster vaccine development by predicting T cell epitopes
An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...
Live Science on MSN5d
1 in 22 COVID survivors develop debilitating chronic syndrome
A study suggests that catching COVID-19 significantly raises the risk of developing ME/CFS (formerly called "chronic fatigue ...
Too Old to Operate6d
Impact of Letermovir Prophylaxis on EBV Reactivation After Haploidentical HSCT
The following is a summary of “Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Atara Biotherapeutics, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / January 29, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
BioSpace1d
Atara to Cut Half Its Workforce Following FDA-Related Setbacks
Atara Biotherapeutics’ layoffs could leave the biotech with around 80 employees. The cuts follow news that the FDA rejected ...